BMJ · 1992 · 32 citations · 3 references
MedicineInfectious DiseasesInternal MedicineHepatologyMedical MicrobiologyVirologyCompartment SyndromeViral HepatitisHepatitis B E AntigenHepatitis Virus DiagnosisHepatitis Virus TestingSerum Alanine AminotransferaseViral Hepatitis Assessment
and clinicoserological evaluation.Mean ages of donors and partners were: group 1, 52-6 and 51 9 years; group 2, 48-0 and 47 4 years; and group 3, 46 3 and 46-8 years.All serum samples tested for alanine aminotransferase activity, hepatitis B surface antigen, and anti-HIV were screened with Abbott hepatitis C virus enzyme immunoassay, second generation kit.In group 1, 10 partners (six men) tested anti-HCV positive, and in group 2 three partners (two men) tested positive.Among the partners of controls one woman tested anti-HCV positive (table).(This last result (1 -5%) is Prevalence of anti-HCVpositive subjects in groups 1-4* 1 la lb 2 3 4 No anti-HC%V negative 33 22 11 40 67 23 No (O/0) anti-HCV positive 10 (23 3) 7 (24 1) 3 (21 4) 3 (7 0) 1 (1 5) 0 Total 43 29 14 43 68 23 X Test (three degrees of freedom) 19 8; p < 00005.*Group 1: heterosexual partners of anti-HCV positive blood donors with chronic liver disease (subset la) or previously abnormal alanine aminotransferase activities (subset lb); group 2: heterosexual partners of anti-HCV positive donors without previously known abnormal alanine aminotransferase activities; group 3: controls (heterosexual partners of random anti-HCV negative donors); group 4: children or other family members of anti-HCV positive subjects.consistent with findings in Piedmont among people of the same age range.Serum samples from the 14 partners positive for anti-HCV were tested with a recombinant immunoblot assay (Ortho) capable of detecting antibodies to antigens 5-1-1, c-100-3, c22-3, and c33c.All gave positive results with at least two antigens.Identical antigenic specificities were observed in seven of the 13 couples in whom both partners were anti-HCV positive.Among 23 children or other family members of anti-HCV positive subjects (group 4; mean age 14-3 years) none (15 in group 1 families, eight in group 2) tested positive (table).
3